Arcinova provides full synthesis of drug substance and support services to a number of key US Biotech clients with a track record in delivering on projects and in the provision of drug substance manufacturing technology, which our clients are patenting.
We run a one stop development and kilo scale manufacturing facility, ensuring a service provision of manufacturing processes, which can be scaled from grams to multi-kg batch size with further kilolab/pilot plant capabilities up to 100’s Kg. We are strong in route selection, process development and impurity tracking / control through our onsite process chemistry, radiolabelled synthesis, analytical and drug development teams. We innovatively develop bespoke solutions for technically difficult challenges and give our customers a better deal in terms of speed, cost and quality.
BioNH's 2019 Annual Dinner Meeting & Innovation CelebrationThe annual dinner meeting and innovation celebration will be attended by Masha Kononov, Senior Director Emerging Pharma US.
BioNH's 2019 Annual Dinner Meeting & Innovation CelebrationDates: 7th FebruaryLocation: New Brunswick, NJ
CED Life ScienceThe CED Life Science Conference will be attended by Masha Kononov, Senior Director Emerging Pharma US and Gail Frey, Senior Director Key Accounts US.
CED Life ScienceDates: 16th - 17th FebruaryLocation: Raleigh, NC
Drug Delivery & Formulation SummitThe DDF Summit 2019 will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
Drug Delivery & Formulation SummitDates: 11th - 13th MarchLocation: Berlin, Germany